the aid library

Filter

8059

Pocket Manual for the Diagnosis and Treatment of Malaria

Olumese P., Al Zedjali M.S., Al-Mukhaini S. Ministry of Health, Sultanate of Oman - Department of Malaria Eradication (2025) C2

The "Pocket Manual for the Diagnosis and Treatment of Malaria", published by the Ministry of Health of the Sultanate of Oman, provides practical guidance for healthcare professionals on how to identify, manage, and treat malaria cases. It emphasizes parasitological confirmation before treatment, out ... more

Renforcement des capacités de lutte contre le paludisme : Guide du conseiller

HRH2030 (Human Resources for Health in 2030) USAID (United States Agency for International Development) (2021) C2

Le document intitulé « Guide du conseiller – Renforcement des capacités de lutte contre le paludisme » est un guide pratique destiné aux conseillers techniques travaillant au sein des Programmes nationaux de lutte contre le paludisme (PNLP), principalement dans des pays partenaires souten ... more

Cholera Outbreak in Haiti. Situation Report, n. 8 (13 March 2024)

Pan American Health Organization (PAHO) (2024) C_WHO

The report provides an update on the cholera outbreak in Haiti as of January and February 2024. A total of 79,411 suspected cases have been reported, with 4,608 confirmed cases and 1,172 deaths across all 10 departments. The most affected regions include Ouest, Centre, Artibonite, and Nord, with chi ... more

SITREP N° 05 DU 22 au 23 JUILLET 2023 Épidémies de Choléra, Shigellose et Salmonellose au Congo

World Health Organisation (WHO) (2023) C_WHO

Le rapport décrit la situation épidémiologique au Congo entre le 22 et le 23 juillet 2023, mettant en évidence les épidémies de choléra, de shigellose et de salmonellose. Il mentionne 19 cas confirmés de choléra, 3 de shigellose et 3 de salmonellose, ainsi que 63 cas d'intoxication alimenta ... more

Diarrhoea Treatment Guidelines
recommended

The MOST Project USAID (2005) C_WHO

The WHO page addresses diarrhoeal diseases, one of the leading causes of death among children under five, which can be prevented through clean water, improved hygiene, and vaccinations. It emphasizes the importance of oral rehydration solutions (ORS) and zinc supplementation for treatment, as well a ... more

Actualización epidemiológica - Cólera - 25 de octubre de 2022

Pan American Health Organization (PAHO) (2022) C_WHO

Desde la notificación de los dos primeros casos confirmados de Vibrio cholerae O1 en el área del gran Puerto Príncipe el 2 de octubre de 2022, al 23 de octubre de 2022, el Ministerio de Salud de Haití (Ministère de la Santé Publique et de la Population, MSPP por sus siglas en francés), inform ... more

Epidemiological Update - Cholera - 17 January 2023

Pan American Health Organization (PAHO) (2023) C_WHO

The report provides an epidemiological update on cholera outbreaks in Haiti as of January 17, 2023. Since the first confirmed cases in October 2022, Haiti has reported 24,232 suspected cases, including 1,742 confirmed cases and 483 deaths. The most affected areas are in the Ouest Department, particu ... more

Déploiement du traitement préventif intermittent du paludisme pendant la grossesse à base de sulfadoxine-pyriméthamine dans les communautés: guide du terrain

Organisation Mondiale de la Santé OMS (2024) C_WHO

Le guide décrit les étapes essentielles et donne des orientations aux pays pour l’adoption et le déploiement du c-TPIg de manière à l’intégrer dans le système de santé existant. Il s’appuie sur les meilleures pratiques et les enseignements tirés des expériences pilotes dans 8 pays af ... more

Malaria in Children

Temu A., Kabyemela G. (2025) C2

Malaria in children presents significant clinical challenges, with variations in presentation based on the malaria parasite involved and the child's underlying health conditions. The World Health Organization reports high incidence rates, particularly in sub-Saharan Africa, and emphasizes the import ... more

World malaria report 2025. Excecutive Summary
recommended

World Health Organisation WHO (2025) C_WHO

Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b ... more

Resumen ejecutivo: Informe mundial sobre la malaria 2025
recommended

World Health Organisation WHO (2025) C_WHO

Este resumen ejecutivo ofrece una visión general completa de los mensajes clave, los datos y las tendencias del Informe mundial sobre la malaria 2025.

Paludisme: Actualités 2024

Aubry, P.; and B.-A. Gaüzère (2025) C2

Depuis 2010, la lutte contre le paludisme a permis de réaliser des progrès majeurs grâce à la distribution de moustiquaires, au diagnostic rapide, aux traitements à base d'artémisinine (ACT) et aux interventions préventives ciblées.

Health care waste management assessment tool

World Health Organization (2001)

Poorly Designed PPE a Global Problem forWomen HealthWorkers

Kuehn, B.M. (2022) C1

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Une meilleure gestion des déchets d’activités de soins

Rushbrook, R.; Zghondi, R. OMS; Banque Mondiale (2005) C_WHO

Une composante intégrale de l’investissement dans la santé

For Proper Disposal Hospital Waste

Jorge Emmanuel and Ruth Stringer Health Care Without Harm (2007)

A Global Inventory of Alternative Medical Waste Treatment Technologies

Règlement sanitaire international (2005) Domaines de travail pour la mise en oeuvre du Règlement

Organisation de la Santé Mondiale (2007)

SSI Prevention - CORRECT AND SAFE SURGICAL ANTIBIOTIC PROPHYLAXIS

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO

HIV Prevention Protocols

World Health Organization (2014) C_WHO

Accessed 24 June 2014